Compare Artra Group Corp. with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROCE of 1.24%
- The company has been able to generate a Return on Capital Employed (avg) of 1.24% signifying low profitability per unit of total capital (equity and debt)
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -12.20
3
With a growth in Net Profit of 91.23%, the company declared Very Positive results in Dec 25
4
With ROE of 0.60%, it has a risky valuation with a 1.10 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
JPY 1,821 Million (Micro Cap)
185.00
NA
0.00%
0.00
13.90%
1.13
Revenue and Profits:
Net Sales:
1,099 Million
(Quarterly Results - Dec 2025)
Net Profit:
79 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-25.91%
0%
-25.91%
6 Months
-28.86%
0%
-28.86%
1 Year
8.33%
0%
8.33%
2 Years
-18.75%
0%
-18.75%
3 Years
-21.43%
0%
-21.43%
4 Years
-44.14%
0%
-44.14%
5 Years
-59.94%
0%
-59.94%
Artra Group Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.18%
EBIT Growth (5y)
16.83%
EBIT to Interest (avg)
-12.20
Debt to EBITDA (avg)
2.55
Net Debt to Equity (avg)
0.17
Sales to Capital Employed (avg)
1.54
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.24%
ROE (avg)
1.63%
Valuation key factors
Factor
Value
P/E Ratio
185
Industry P/E
Price to Book Value
1.10
EV to EBIT
139.50
EV to EBITDA
10.72
EV to Capital Employed
1.09
EV to Sales
0.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.78%
ROE (Latest)
0.60%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
1,099.40
1,151.40
-4.52%
Operating Profit (PBDIT) excl Other Income
78.70
80.00
-1.62%
Interest
3.50
3.20
9.37%
Exceptional Items
0.00
-4.60
100.00%
Consolidate Net Profit
79.40
41.50
91.33%
Operating Profit Margin (Excl OI)
47.20%
35.40%
1.18%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is -4.52% vs -15.03% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 91.33% vs -70.01% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
3,927.20
4,234.40
-7.25%
Operating Profit (PBDIT) excl Other Income
246.20
160.00
53.88%
Interest
13.90
13.70
1.46%
Exceptional Items
0.50
-28.60
101.75%
Consolidate Net Profit
258.30
-36.70
803.81%
Operating Profit Margin (Excl OI)
35.90%
1.30%
3.46%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -7.25% vs -5.85% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 803.81% vs -167.96% in Dec 2024
About Artra Group Corp. 
Artra Group Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






